Certified by Founder Lodge
Boehringer Ingelheim
Germany - Ingelheim am Rhein, Rhineland-Palatinate
INVESTOR
1 Disclosed Funding Rounds $5,198,000
5 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates
Company | Date | Round | Raised |
---|---|---|---|
C-mo Medical Solutions | January, 31 ,2023 | Seed | $5,198,000 |
DiogenX | May, 11 ,2023 | Series A | $30,056,125 |
Otto | September, 01 ,2023 | Series B | $43,000,000 |
Actym Therapeutics, Inc. | October, 20 ,2023 | Series A | $59,500,000 |
GLOX Therapeutics Ltd. | November, 15 ,2023 | Unknown | $5,362,000 |